Search

Joseph A Kaufman

Examiner (ID: 10129)

Most Active Art Unit
3754
Art Unit(s)
3752, 3993, 3727, 3754, 3108, 3104
Total Applications
1964
Issued Applications
1543
Pending Applications
181
Abandoned Applications
196

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 122132 [patent_doc_number] => 07709617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy' [patent_app_type] => utility [patent_app_number] => 11/173983 [patent_app_country] => US [patent_app_date] => 2005-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 37 [patent_no_of_words] => 20812 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709617.pdf [firstpage_image] =>[orig_patent_app_number] => 11173983 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/173983
Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy Jun 30, 2005 Issued
Array ( [id] => 5720352 [patent_doc_number] => 20060073126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Cytotoxic T lymphocyte' [patent_app_type] => utility [patent_app_number] => 11/171365 [patent_app_country] => US [patent_app_date] => 2005-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12410 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073126.pdf [firstpage_image] =>[orig_patent_app_number] => 11171365 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/171365
Cytotoxic T lymphocyte Jun 30, 2005 Abandoned
Array ( [id] => 891675 [patent_doc_number] => 07344883 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'Complementing cell lines' [patent_app_type] => utility [patent_app_number] => 11/165697 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 24569 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/344/07344883.pdf [firstpage_image] =>[orig_patent_app_number] => 11165697 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/165697
Complementing cell lines Jun 23, 2005 Issued
Array ( [id] => 4745271 [patent_doc_number] => 20080089873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Method for Regenerating Hair Follicles by Suppressing a Gene with Hair Follicle Formation-Inhibiting Ability or by Activating a Gene with Hair Follicle Formation-Inducing Ability' [patent_app_type] => utility [patent_app_number] => 11/629281 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8553 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089873.pdf [firstpage_image] =>[orig_patent_app_number] => 11629281 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/629281
Method for Regenerating Hair Follicles by Suppressing a Gene with Hair Follicle Formation-Inhibiting Ability or by Activating a Gene with Hair Follicle Formation-Inducing Ability Jun 9, 2005 Abandoned
Array ( [id] => 4476646 [patent_doc_number] => 07906312 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator' [patent_app_type] => utility [patent_app_number] => 11/148368 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 10 [patent_no_of_words] => 14955 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906312.pdf [firstpage_image] =>[orig_patent_app_number] => 11148368 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/148368
Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator Jun 8, 2005 Issued
Array ( [id] => 6931238 [patent_doc_number] => 20050282273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Medium and methods for culturing of avian primordial germ cells' [patent_app_type] => utility [patent_app_number] => 11/148039 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8868 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282273.pdf [firstpage_image] =>[orig_patent_app_number] => 11148039 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/148039
Medium and methods for culturing of avian primordial germ cells Jun 7, 2005 Abandoned
Array ( [id] => 5705704 [patent_doc_number] => 20060194752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Treatment for renal disease' [patent_app_type] => utility [patent_app_number] => 11/147500 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11806 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194752.pdf [firstpage_image] =>[orig_patent_app_number] => 11147500 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/147500
Treatment for renal disease Jun 6, 2005 Abandoned
Array ( [id] => 4431723 [patent_doc_number] => 07968334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing' [patent_app_type] => utility [patent_app_number] => 11/141447 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 57 [patent_no_of_words] => 19047 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968334.pdf [firstpage_image] =>[orig_patent_app_number] => 11141447 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/141447
Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing May 30, 2005 Issued
Array ( [id] => 5819966 [patent_doc_number] => 20060024279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Retroviral vectors' [patent_app_type] => utility [patent_app_number] => 11/139766 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6843 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024279.pdf [firstpage_image] =>[orig_patent_app_number] => 11139766 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/139766
Retroviral vectors May 26, 2005 Abandoned
Array ( [id] => 6958372 [patent_doc_number] => 20050214742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Screen for CDC7 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/129586 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8894 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214742.pdf [firstpage_image] =>[orig_patent_app_number] => 11129586 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/129586
Screen for CDC7 inhibitors May 12, 2005 Abandoned
Array ( [id] => 5738493 [patent_doc_number] => 20060008884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/127832 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21043 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008884.pdf [firstpage_image] =>[orig_patent_app_number] => 11127832 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/127832
Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof May 11, 2005 Issued
Array ( [id] => 5776312 [patent_doc_number] => 20060104952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Genomic barrier to viral disease' [patent_app_type] => utility [patent_app_number] => 11/124312 [patent_app_country] => US [patent_app_date] => 2005-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8566 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104952.pdf [firstpage_image] =>[orig_patent_app_number] => 11124312 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/124312
Genomic barrier to viral disease May 5, 2005 Abandoned
Array ( [id] => 5769527 [patent_doc_number] => 20050266020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Modular transport systems for molecular substances and production and use thereof' [patent_app_type] => utility [patent_app_number] => 11/120543 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11612 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266020.pdf [firstpage_image] =>[orig_patent_app_number] => 11120543 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/120543
Modular transport systems for molecular substances and production and use thereof May 1, 2005 Abandoned
Array ( [id] => 5793488 [patent_doc_number] => 20060014169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Methods for obtaining directionally truncated polypeptides' [patent_app_type] => utility [patent_app_number] => 11/093387 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15203 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014169.pdf [firstpage_image] =>[orig_patent_app_number] => 11093387 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/093387
Methods for obtaining directionally truncated polypeptides Mar 29, 2005 Issued
Array ( [id] => 10629788 [patent_doc_number] => 09347936 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Inactive Ca2+/calmodulin-dependent protein kinase IIα knockin animal and knockin cell of the same' [patent_app_type] => utility [patent_app_number] => 10/599460 [patent_app_country] => US [patent_app_date] => 2005-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 6911 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10599460 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/599460
Inactive Ca2+/calmodulin-dependent protein kinase IIα knockin animal and knockin cell of the same Mar 23, 2005 Issued
Array ( [id] => 5894912 [patent_doc_number] => 20060003451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus' [patent_app_type] => utility [patent_app_number] => 11/075385 [patent_app_country] => US [patent_app_date] => 2005-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7135 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003451.pdf [firstpage_image] =>[orig_patent_app_number] => 11075385 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/075385
Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus Mar 7, 2005 Abandoned
Array ( [id] => 6931245 [patent_doc_number] => 20050282280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Oncolytic adenoviral vectors encoding GM-CSF' [patent_app_type] => utility [patent_app_number] => 11/066480 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 27044 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282280.pdf [firstpage_image] =>[orig_patent_app_number] => 11066480 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/066480
Oncolytic adenoviral vectors encoding GM-CSF Feb 27, 2005 Abandoned
Array ( [id] => 7077731 [patent_doc_number] => 20050150003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Method for improving phytoremediation treatment of a contaminated medium' [patent_app_type] => utility [patent_app_number] => 11/056502 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6836 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20050150003.pdf [firstpage_image] =>[orig_patent_app_number] => 11056502 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/056502
Method for improving phytoremediation treatment of a contaminated medium Feb 10, 2005 Abandoned
Array ( [id] => 7110609 [patent_doc_number] => 20050208064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide' [patent_app_type] => utility [patent_app_number] => 11/050679 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6108 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208064.pdf [firstpage_image] =>[orig_patent_app_number] => 11050679 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/050679
Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide Feb 6, 2005 Abandoned
Array ( [id] => 6977832 [patent_doc_number] => 20050287550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Bacterial counterselectable hybrid systems' [patent_app_type] => utility [patent_app_number] => 11/050174 [patent_app_country] => US [patent_app_date] => 2005-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 23116 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287550.pdf [firstpage_image] =>[orig_patent_app_number] => 11050174 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/050174
Bacterial counterselectable hybrid systems Feb 1, 2005 Issued
Menu